1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. (19th October 2021) Authors: O'Kane, D.; McCourt, C.; Meggitt, S.; D'Cruz, D.P.; Orteu, C.H.; Benton, E.; Wahie, S.; Utton, S.; Hashme, M.; Mohd Mustapa, M.F.; Exton, L.S. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. (1st December 2021) Authors: O'Kane, D.; McCourt, C.; Meggitt, S.; D'Cruz, D.P.; Orteu, C.H.; Benton, E.; Wahie, S.; Utton, S.; Hashme, M.; Mohd Mustapa, M.F.; Exton, L.S. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Proton pump inhibitor‐induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus. (1st October 2015) Authors: Hung, R.; Sangle, S. R.; Benton, E.; D'Cruz, D. P.; McGibbon, D. Journal: Clinical and experimental dermatology Issue: Volume 40:Number 7(2015) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Proton pump inhibitor‐induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus. (21st March 2015) Authors: Hung, R.; Sangle, S. R.; Benton, E.; D'Cruz, D. P.; McGibbon, D. Journal: Clinical and experimental dermatology Issue: Volume 40:Number 7(2015) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Two cases of bilateral earlobe cutaneous pseudolymphoma. (1st December 2014) Authors: Laftah, Z.; Benton, E.; Bhargava, K.; Ross, J.; Millard, T.; Craig, P.; Calonje, E. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Two cases of bilateral earlobe cutaneous pseudolymphoma. (9th November 2014) Authors: Laftah, Z.; Benton, E.; Bhargava, K.; Ross, J.; Millard, T.; Craig, P.; Calonje, E. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗